Clinical Trial Update: Vaccine Treatment for Advanced Malignant Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of a vaccine treatment for advanced malignant melanoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Snippet

Sponsor: NewLink Genetics Corporation | Conditions: Malignant Melanoma | Phase 1, Phase 2 | Status: COMPLETED